Zhang et al. [29], in their group of newly diagnosed multiple myeloma (NDMM) patients, detected frequencies of Bregs within the CD19+ B cells in the peripheral blood which were not significantly different from those observed in the healthy subjects (5.44 ± 1.97% versus 4.56 ± 0.86%). The gene discussed is CD19; the disease is AL amyloidosis.